The iron-binding protein lactotransferrin is present in pathologic lesions in a variety of neurodegenerative disorders: a comparative immunohistochemical analysis

[1]  D. Sparks,et al.  Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease. , 1995, Archives of neurology.

[2]  J. Morrison,et al.  Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital. , 1994, Cerebral cortex.

[3]  J. Connor,et al.  Iron in the brain. , 2009, Nutrition reviews.

[4]  K. Jellinger,et al.  Microglial reaction in Pick's disease , 1993, Neuroscience Letters.

[5]  P. Rainard.  Activation of the classical pathway of complement by binding of bovine lactoferrin to unencapsulated Streptococcus agalactiae. , 1993, Immunology.

[6]  D. Legrand,et al.  Lactotransferrin binding to its platelet receptor inhibits platelet aggregation. , 1993, European journal of biochemistry.

[7]  D. Walker,et al.  Lactotransferrin immunocytochemistry in Alzheimer and normal human brain. , 1993, The American journal of pathology.

[8]  J. Morrison,et al.  Neurofibrillary tangle densities in the hippocampal formation in a non-demented population define subgroups of patients with differential early pathologic changes , 1993, Neuroscience Letters.

[9]  A. Delacourte,et al.  Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide , 1993, Brain Research.

[10]  B. Giometto,et al.  Transferrin Receptors in the Central Nervous System , 1993 .

[11]  W. Hurley,et al.  Heparin-binding properties of lactoferrin and lysozyme. , 1992, Comparative biochemistry and physiology. B, Comparative biochemistry.

[12]  R. Hamelin,et al.  Characterization of lactotransferrin receptor in epithelial cell lines from non-malignant human breast, benign mastopathies and breast carcinomas. , 1992, Anticancer research.

[13]  J. Morrison,et al.  Progressive transformation of the cytoskeleton associated with normal aging and Alzheimer's disease , 1992, Brain Research.

[14]  C. W. Olanow,et al.  Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study , 1992, Brain Research.

[15]  C. Morris,et al.  Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's-disease and chronic renal-dialysis patients. , 1992, The Biochemical journal.

[16]  J. Morrison,et al.  Evidence for early vulnerability of the medial and inferior aspects of the temporal lobe in an 82-year-old patient with preclinical signs of dementia. Regional and laminar distribution of neurofibrillary tangles and senile plaques. , 1992, Archives of neurology.

[17]  R. Kalaria,et al.  Transferrin receptors of rat and human brain and cerebral microvessels and their status in Alzheimer's disease , 1992, Brain Research.

[18]  D. Perl,et al.  Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: A laser microprobe (LAMMA) study , 1992, Annals of neurology.

[19]  Bradley T. Hyman,et al.  Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease , 1992, Neurology.

[20]  J. Gutteridge,et al.  Iron and oxygen radicals in brain , 1992, Annals of neurology.

[21]  J. Connor,et al.  Iron regulation in the brain: Histochemical, biochemical, and molecular considerations , 1992, Annals of neurology.

[22]  J. Morrison,et al.  Neurofibrillary tangle distribution in the cerebral cortex of parkinsonism-dementia cases from Guam: differences with Alzheimer's disease , 1991, Brain Research.

[23]  S. Klebanoff,et al.  Prooxidant activity of transferrin and lactoferrin , 1990, The Journal of experimental medicine.

[24]  J. V. Dijk,et al.  The biology of transferrin. , 1990 .

[25]  E. Larkin,et al.  Importance of Fetal and Neonatal Iron: Adequacy for Normal Development of Central Nervous System , 1990 .

[26]  K. Jellinger,et al.  Brain iron and ferritin in Parkinson's and Alzheimer's diseases , 1990, Journal of neural transmission. Parkinson's disease and dementia section.

[27]  P. Mcgeer,et al.  Activation of the classical complement pathway in brain tissue of Alzheimer patients , 1989, Neuroscience Letters.

[28]  L. Davidson,et al.  Fe-saturation and proteolysis of human lactoferrin: effect on brush-border receptor-mediated uptake of Fe and Mn. , 1989, The American journal of physiology.

[29]  A. Delacourte,et al.  Alzheimer's disease: glycolytic pretreatment dramatically enhances immunolabeling of senile plaques and cerebrovascular amyloid substance. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[30]  D. Legrand,et al.  Expression of human lactotransferrin receptors in phytohemagglutinin-stimulated human peripheral blood lymphocytes. Isolation of the receptors by antiligand-affinity chromatography. , 1989, European journal of biochemistry.

[31]  J. Brock,et al.  Iron in immunity, cancer and inflammation , 1989 .

[32]  D. Nochlin,et al.  The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. , 1988, The American journal of pathology.

[33]  N. E. Hansen,et al.  Lactoferrin‐mediated transfer of iron to intracellular ferritin in human monocytes , 1988, European journal of haematology.

[34]  G. Sawatzki,et al.  Lactotransferrin receptor of mouse small-intestinal brush border. Binding characteristics of membrane-bound and triton X-100-solubilized forms. , 1988, The Biochemical journal.

[35]  Moussa B. H. Youdim,et al.  Brain iron : neurochemical and behavioural aspects , 1988 .

[36]  A. Pouplard-Barthelaix.  Immunological Markers and Neuropathological Lesions in Alzheimer’s Disease , 1988 .

[37]  H. Bebie,et al.  Plasmalactoferrin and the plasmalactoferrin/neutrophil ratio. A reassessment of normal values and of the clinical relevance. , 1988, Acta haematologica.

[38]  P. Mcgeer,et al.  Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR , 1987, Neuroscience Letters.

[39]  Y. Yamada,et al.  Lactoferrin binding by leukemia cell lines. , 1987, Blood.

[40]  R. Garruto,et al.  Neurodegenerative disorders of the western pacific: the search for mechanisms of pathogenesis , 1986, Trends in Neurosciences.

[41]  D. Perl,et al.  Aluminum Neurotoxicity — Potential Role in the Pathogenesis of Neurofibrillary Tangle Formation , 1986, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[42]  H. Broxmeyer.  Biomolecule-cell interactions and the regulation of myelopoiesis. , 1986, International journal of cell cloning.

[43]  J. Montreuil,et al.  Visualization of lactotransferrin brush-border receptors by ligand-blotting. , 1985, Biochimica et biophysica acta.

[44]  Joannam . Hill.  Iron concentration reduced in ventral pallidum, globus pallidus, and substantia nigra by GABA-transaminase inhibitor, gamma-vinyl GABA , 1985, Brain Research.

[45]  F. Schoentgen,et al.  Human lactotransferrin: amino acid sequence and structural comparisons with other transferrins. , 1984, European journal of biochemistry.

[46]  W. Jefferies,et al.  Transferrin receptor on endothelium of brain capillaries , 1984, Nature.

[47]  C. Figarella,et al.  A non competitive enzyme immunoassay of human lactoferrin in biological fluids. , 1983, Clinica chimica acta; international journal of clinical chemistry.

[48]  D. Perl,et al.  Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and Parkinsonism-dementia of Guam. , 1982, Science.

[49]  J. V. Bannister,et al.  Enhanced production of hydroxyl radicals by the xanthine-xanthine oxidase reaction in the presence of lactoferrin. , 1982, Biochimica et biophysica acta.

[50]  G. Strecker,et al.  Primary structure of the glycans from human lactotransferrin. , 1982, European journal of biochemistry.

[51]  R. Johnston,et al.  Lactoferrin enhances hydroxyl radical production by human neutrophils, neutrophil particulate fractions, and an enzymatic generating system. , 1981, The Journal of clinical investigation.

[52]  P. Venge,et al.  Lactoferrin, Lysozyme, and β2‐Microglobulin in Cerebrospinal Fluid: Elevated Levels in Patients with Acute Cerebrovascular Lesions as Indices of Inflammation , 1981, Stroke.

[53]  D. Perl,et al.  Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons. , 1980, Science.

[54]  J. Montreuil,et al.  Iron binding proteins and influx of iron across the duodenal brush border. Evidence for specific lactotransferrin receptors in the human intestine. , 1979, Biochimica et biophysica acta.

[55]  D. Crapper,et al.  Brain Aluminum Distribution in Alzheimer's Disease and Experimental Neurofibrillary Degeneration , 1973, Science.

[56]  M. Baggiolini,et al.  ASSOCIATION OF LACTOFERRIN WITH SPECIFIC GRANULES IN RABBIT HETEROPHIL LEUKOCYTES , 1970, The Journal of experimental medicine.

[57]  J. Heremans,et al.  An iron-binding protein common to many external secretions , 1966 .

[58]  B. Hallgren,et al.  THE EFFECT OF AGE ON THE NON‐HAEMIN IRON IN THE HUMAN BRAIN , 1958, Journal of neurochemistry.